RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
T2 Biosystems Stock

T2 Biosystems Dividend 2024

T2 Biosystems Dividend

0 USD

T2 Biosystems Dividend yield

Ticker

TTOO

ISIN

US89853L1044

WKN

A119H3

How much dividend does T2 Biosystems 2024 pay?

According to the latest status from December 2024, T2 Biosystems paid a total of 0 USD per share in dividends within the last 12 months. With the current T2 Biosystems price of 0 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical T2 Biosystems Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the T2 Biosystems Dividend Safe?

T2 Biosystems has been increasing the dividend for 0 years.

Over the past 10 years, T2 Biosystems has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding T2 Biosystems's Dividend Distributions

T2 Biosystems’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining T2 Biosystems's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

T2 Biosystems's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in T2 Biosystems’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

T2 Biosystems Aktienanalyse

What does T2 Biosystems do?

T2 Biosystems Inc. is an American company that was founded in 2006. The company is based in Lexington, Massachusetts. The founders of T2 Biosystems aimed to create an innovative diagnostic system that could improve hospital performance. Their business model is based on the development, manufacturing, and distribution of innovative instruments and diagnostic solutions. T2 Biosystems operates in various sectors, with a focus on diagnosis and healthcare solutions. The key areas are: 1. Infectious diseases: T2 Biosystems develops systems that enable rapid and accurate diagnosis of infectious diseases in hospitals and other medical facilities. The team has already made significant progress in detecting infections such as sepsis, pneumonia, and other diseases that require prompt diagnosis to increase patient survival rates. 2. Hematology: The company has also developed a product called T2HemoStat, which improves accuracy in determining biomarkers in blood samples. HemoStat allows for real-time analysis of patient samples to achieve faster results than current standard tests. 3. Healthcare: T2 Biosystems also offers solutions to improve healthcare. The goal is to address issues in healthcare by using data and information more intelligently. The company is working on products tailored to the needs of hospitals and healthcare providers. T2 Biosystems pursues a collaborative strategy, fostering cooperation among clinics, customers, and companies. T2 Biosystems has successfully launched several products, including the T2Dx instrument, which enables rapid and accurate detection of infections. The measurement system is based on T2 Magnetic Resonance (T2MR) technology, which can identify cells and biomolecules based on magnetic resonance. The T2Dx system is also capable of identifying drugs directly in the tests, allowing for better utilization of antibiotics to combat resistant bacteria. In collaboration with Harvard Medical School, the company is also working on developing specific tests focused on the detection of bacteria or viruses. The team at T2 Biosystems has developed an innovative system that allows for the analysis of bacterial or viral strains. T2 Biosystems has a rapidly growing customer base and is a key player in the healthcare market. The company has already established important partnerships with some of the leading hospitals in the US and continues to work on forming further partnerships in other parts of the world. The products of T2 Biosystems have received numerous awards, including the "Best of Show" prize at the Association of Clinical Chemistry Annual Meeting and the "Medical Device Excellence Award" from the Massachusetts Medical Device Industry Council. The company operates in a highly competitive market. To remain competitive, T2 Biosystems heavily invests in research and development. The company also has a strong presence on social media to raise awareness of their products and services. T2 Biosystems aims to achieve further medical advancements and develop innovative technologies to improve patient care in the future. T2 Biosystems is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about T2 Biosystems stock

How much dividend does T2 Biosystems pay?

Over the past 12 months, T2 Biosystems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, T2 Biosystems is expected to pay a dividend of 0 USD.

What is the dividend yield of T2 Biosystems?

The current dividend yield of T2 Biosystems is .

When does T2 Biosystems pay dividends?

T2 Biosystems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of T2 Biosystems?

T2 Biosystems paid dividends every year for the past 0 years.

What is the dividend of T2 Biosystems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is T2 Biosystems located?

T2 Biosystems is assigned to the 'Health' sector.

Wann musste ich die Aktien von T2 Biosystems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of T2 Biosystems from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did T2 Biosystems pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of T2 Biosystems in the year 2023?

In the year 2023, T2 Biosystems distributed 0 USD as dividends.

In which currency does T2 Biosystems pay out the dividend?

The dividends of T2 Biosystems are distributed in USD.

Andere Kennzahlen von T2 Biosystems

Our stock analysis for T2 Biosystems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of T2 Biosystems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.